Elevian develops regenerative medicines that target root-cause aging mechanisms. We are a spin out from Harvard, led by a team of serial entrepreneurs and Harvard scientists.
Elevian’s founders have identified blood factors that regulate aging and stimulate the body’s natural repair and regeneration mechanisms. One well published example, GDF11, reduces age-related cardiac hypertrophy, accelerates skeletal muscle repair, and improves cognitive function in aged mammals. We are developing biotherapeutics that regulate these blood factors.
By targeting root-cause aging mechanisms, Elevian's therapeutics have the potential to treat or prevent multiple degenerative diseases and extend healthy lifespan.
Elevian’s founders have identified blood factors that regulate aging and stimulate the body’s natural repair and regeneration mechanisms. One well published example, GDF11, reduces age-related cardiac hypertrophy, accelerates skeletal muscle repair, and improves cognitive function in aged mammals. We are developing biotherapeutics that regulate these blood factors.
By targeting root-cause aging mechanisms, Elevian's therapeutics have the potential to treat or prevent multiple degenerative diseases and extend healthy lifespan.
Location: United States, Massachusetts, Boston
Employees: 11-50
Total raised: $95M
Founded date: 2017
Investors 5
| Date | Name | Website |
| - | Western Te... | westerntec... |
| - | Bold Capit... | boldcapita... |
| - | Formic Ven... | formic.vc |
| - | For Good V... | forgoodven... |
| - | ARTEFIN | artefin-ve... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 03.12.2021 | Series A | $40M | - |
| 16.09.2021 | Series A | $40M | - |
| 24.11.2020 | - | $15M | - |
Mentions in press and media 17
| Date | Title | Description |
| 10.03.2023 | Tweekly. Выпуск 160. Бессмертие как сервис | Что сейчас растёт и как это применить 1. Бессмертие как сервис (IaaS). То, чего все хотят и боятся одновременно. 2. Цифровые клоны городов и производств — быстрая проверка «капиталоемких» гипотез. Следующий шаг - проверка жизнеспособности п... |
| 05.11.2021 | Kuelbs Family Office Invests in Biotech Company Elevian, Supporting $40 Million Funding Round | DALLAS (PRWEB) November 05, 2021 Texas-based investor John A. Kuelbs announces his commitment to transformative health initiatives with his investment in Elevian, an emerging biotech company developing medicines that restore youthful regene... |
| 17.09.2021 | Elevian snags $40M for stroke recovery and age-related diseases How to Optimize In Vitro and In Vivo Data Analysis and Data Management in Drug Research | Elevian thinks it has the tools to treat age-related diseases and will start by testing its drug in one of the leading causes of death: strokes. The Massachusetts biotech raised $40 million to bankroll studies based on research that emerged... |
| 17.09.2021 | When startup exits aren’t such good news | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. An exit—in which a company is sold—is often hailed as a celebratory event. There’s practically a ... |
| 17.09.2021 | Elevian snags $40M for stroke recovery and age-related diseases | - |
| 17.09.2021 | When startup exits aren’t such good news | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content How digital IDs are ready to disrupt airport travel—and more From NEC An exit—in whi... |
| 17.09.2021 | Elevian snags $40M for stroke recovery and age-related diseases | Elevian thinks it has the tools to treat age-related diseases and will start by testing its drug in one of the leading causes of death: strokes. The Massachusetts biotech raised $40 million to bankroll studies based on research that emerged... |
| 17.09.2021 | Elevian Raises $40M Series A | ALLSTON, MA, Elevian, an emerging biotech company, has raised $40 million in an oversubscribed Series A round led by Prime Movers Lab. >> Click here for more funding data on Elevian >> To export Elevian funding data to PDF a... |
| 16.09.2021 | Elevian Raises $40 Million Series A to Advance Treatments for... | - |
| 16.09.2021 | Elevian Raises $40 Million Series A to Advance Treatments for Stroke Recovery and Age-Related Diseases |
Show more